Fintel on MSN1d
Cantor Fitzgerald Upgrades Beam Therapeutics (BEAM)
Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...
The Caledonian Record1d
Trump commerce pick says favors broad tariffs, vows tough China stance
Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...
US commerce secretary pick favors sweeping tariffs, hawkish China stance
Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...
CoinDesk1d
As Lutnick Faces U.S. Senate, Elizabeth Warren Scrutinizes His Tether Ties
Howard Lutnick, President Trump's pick to run the Department of Commerce, is probed by the senator on the Tether connection ...
Bloomberg on MSN1d
Howard Lutnick: Cantor Has a Convertible Bond With Tether
Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...
Lutnick chokes up talking about employees killed on 9/11
Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing ...
Business Insider14d
Nice initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage of Nice (NICE) with a Neutral rating and $176 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze ...
TV Insider14d
‘Survivor’: Michele Fitzgerald Defends ‘Controversial’ Season 32 Win Against Critics (VIDEO)
For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...
Business Insider16d
Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price target of $76.00. The company’s shares ...
Insider Monkey21d
Cantor Fitzgerald Initiates Coverage on Varonis Systems, Inc. (VRNS) with Overweight Rating: AI and Cybersecurity Drive Growth Outlook
We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where Varonis Systems, Inc. (NASDAQ:VRNS) stands against the ...